Brinks Co
F:PTY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Brinks Co
F:PTY
|
US |
|
Sarine Technologies Ltd
SGX:U77
|
IL |
|
Intred SpA
F:M7P
|
IT |
|
Krungthai Card PCL
OTC:KGTHY
|
TH |
|
B
|
Buryatzoloto PAO
MOEX:BRZL
|
RU |
|
Pangenomic Health Inc
F:LL3
|
CA |
|
A
|
Air Products and Chemicals Inc
F:AP3
|
US |
|
P
|
PepsiCo Inc
DUS:PEP
|
US |
|
Charoen Pokphand Indonesia Tbk PT
OTC:PPOKF
|
ID |
|
Renault SA
PAR:RNO
|
FR |
|
T
|
Tempus AI Inc
F:F3M
|
US |
|
U
|
Ultra Brands Ltd
OTC:FLLLF
|
CA |
|
V
|
Vortex Energy Corp
OTC:VTECF
|
CA |
|
V
|
Vienna Insurance Group Wiener Versicherung Gruppe AG
SWB:WSV2
|
AT |
|
M
|
Meribank Biotech Co Ltd
TPEX:4724
|
TW |
|
Saratovenergo PAO
MOEX:SARE
|
RU |
|
I
|
ISS A/S
F:QJQ
|
DK |
|
Professional Diversity Network Inc
NASDAQ:IPDN
|
US |
|
Unggul Indah Cahaya Tbk PT
IDX:UNIC
|
ID |
|
Rapport Therapeutics Inc
NASDAQ:RAPP
|
US |
Earnings Calls
Last Earnings Call
Revenue: Brink's reported a strong second quarter, with revenue up 7% and organic growth of 4%, helped by favorable foreign exchange and continued momentum in higher-margin AMS and DRS businesses.
Margins: EBITDA margin reached a record second-quarter 18.5%, up 70 basis points year over year, and management said the company is ahead of its original full-year expectations.
Outlook: Full-year guidance for 2026 was reaffirmed for mid-single-digit organic growth, but profit expectations were raised after second-quarter EBITDA came in above the midpoint of prior guidance.
AMS/DRS: AMS and DRS grew 14% organically, marking the 14th straight quarter of mid-teens or better growth, and management expects second-half growth to accelerate on the back of new wins and a solid pipeline.
Deal progress: Brink's said the NCR Atleos acquisition is moving ahead, with shareholder approval above 99% and several regulatory clearances already in hand; closing is now expected in early Q1.
Cash flow: Free cash flow remained strong, with trailing 12-month free cash flow of $468 million and conversion of 46%; the company still targets 40% to 45% for the full year.